GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bayzed Health Group 2609.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.62

-2.96%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.12bn

FY2021FY2025

Net income

−CN¥13.0m

FY2021FY2025

Free cash flow

CN¥184.4m

FY2021FY2025

Shareholders' equity

CN¥1.52bn

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
RevenueCN¥1.12bnCN¥1.19bnCN¥1.07bnCN¥802.7mCN¥461.6m
Operating incomeCN¥30.9mCN¥35.0mCN¥22.4m−CN¥38.1m−CN¥40.9m
Net income−CN¥13.0m−CN¥13.5m−CN¥26.4m−CN¥58.0m−CN¥46.1m
Diluted earnings per share-0.01-0.01-0.02-0.04-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assetsCN¥2.56bnCN¥2.20bnCN¥2.21bnCN¥2.11bnCN¥1.76bn
Cash and short-term investmentsCN¥616.0mCN¥294.2mCN¥242.0mCN¥125.2m—
Total liabilitiesCN¥1.04bnCN¥1.13bnCN¥1.13bnCN¥1.12bnCN¥660.3m
DebtCN¥198.3mCN¥202.3mCN¥251.0mCN¥234.2mCN¥111.2m
Shareholders' equityCN¥1.52bnCN¥1.07bnCN¥1.08bnCN¥987.9mCN¥1.02bn
Shares outstanding1,318m1,318m1,318m1,318m1,318m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operationsCN¥222.3mCN¥168.5mCN¥128.4mCN¥114.4mCN¥6.4m
Capital spending−CN¥37.9m−CN¥46.5m−CN¥53.8m−CN¥36.4m−CN¥54.0m
Free cash flowCN¥184.4mCN¥122.1mCN¥74.6mCN¥78.0m−CN¥47.6m

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024
RevenueCN¥545.1mCN¥574.7mCN¥617.9mCN¥570.9m
Operating incomeCN¥30.4mCN¥439,000CN¥23.0mCN¥13.5m
Net incomeCN¥14.7m−CN¥27.6m−CN¥1.9m−CN¥11.5m
Diluted earnings per share0.01-0.02-0.00-0.01
Cash from operations—CN¥89.0mCN¥168.0mCN¥76.0m
Capital spending—−CN¥20.0m−CN¥46.0m−CN¥22.0m
Free cash flow—CN¥69.0mCN¥122.0mCN¥54.0m
Total assetsCN¥2.56bnCN¥2.66bnCN¥2.20bnCN¥2.23bn
Cash and short-term investmentsCN¥616.0mCN¥835.2m——
DebtCN¥198.3mCN¥235.8mCN¥65.1mCN¥71.7m
Shareholders' equityCN¥1.52bnCN¥1.52bnCN¥1.07bnCN¥1.07bn

Financial ratios

Data as of 19 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Operating margin2.8%2.9%2.1%-4.8%-8.9%
Net margin-1.2%-1.1%-2.5%-7.2%-10.0%
Return on equity-0.9%-1.3%-2.4%-5.9%-4.5%
Return on assets-0.5%-0.6%-1.2%-2.7%-2.6%
Free cash flow yield7.4%6.1%———
Revenue growth-5.8%10.9%33.6%73.9%—
Earnings growth-3.7%-49.0%-54.5%25.9%—
Current ratio1.69x0.97x1.00x0.83x1.58x
Debt to equity0.05x0.06x0.09x0.08x0.11x
Equity ratio59.5%48.5%49.0%46.8%57.9%
Interest coverage5.47x12.26x18.51x-29.54x-1.95x
Buybacks as a share of market value0.0%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.7%——
Net income-39.3%——

Valuation history

At each fiscal year end

FY2025
Price to earnings-335.8
Price to sales4.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.